TY  - JOUR
PY  - 2008//
TI  - Medical management of frontotemporal dementia
JO  - Journal of Traumatic Stress
A1  - Caselli, Richard J.
A1  - Yaari, Roy
SP  - 489
EP  - 498
VL  - 22
IS  - 6
N2  - There are no Food and Drug Administration (FDA)-approved medications for the medical management of frontotemporal dementia and its related disorders, so all management recommendations are necessarily off-label and borrowed from experience with Alzheimer's disease, psychiatric disease, and related medical illnesses. Six areas of pharmacotherapeutic consideration are prevention (primary and secondary), intellectual decline, behavioral disorders (such as depression, anxiety, and psychosis), sleep disorders, frequently associated disorders (including motor neuron disease), and abrupt decline. In addition to pharmacotherapy, important lifestyle issues confronting the clinician include driving cessation, securing any weapons maintained at home, assisted living, and caregiver burnout.<p /> <p>Language: en</p> 
LA  - en
SN  - 0894-9867
UR  - http://dx.doi.org/10.1177/1533317507306654
ID  - ref1
ER  -